ELAN logo

ELANCO ANIMAL HEALTH INC

ELANNYSE
πŸ† #657 by market capEarnings Nov 4US Equity
$22.73β–² $0.46 (+2.02%)
πŸŒ™ After hours$22.73β–² 0.00%Regular close Β· extended-hours price shown
1hβ€”
24hβ–² 2.0%
7dβ–Ό 13.3%
14dβ–Ό 13.8%
30dβ–Ό 9.6%
1yβ–² 30.3%
🏦Market Cap
$11.35B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+11.9%
Healthy
πŸ“ŠGross Margin
55.4%
Healthy
πŸ’΅FCF Margin
8.3%
Moderate
βš–οΈP/S Ratio
2.2x
Cheap
Otter Score
62
Fair

Trading Snapshot

Day Range
$22.58 – $22.99
52-Week Range
$16.15 – $27.98
Volume
$3.18B
Avg Volume
$2.44B
Shares Outstanding
499.4M
Next Earnings
Oct 3, 2026

Fundamentals Snapshot

Annual Revenue
$4.71B
Last Q Revenue
$1.37B
P/E Ratio
β€”
P/S Ratio
2.2x
EPS (TTM)
$-0.42
Dividend Yield
β€”

Why Investors Own ELAN

  • βœ“High-growth profile β€” revenue up +12.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 36% gross margin and 12% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$4.71Bβ–² +13.0% YoY
Gross Margin (TTM)
36.4%β–² +4.3% YoY
Operating Income (TTM)
$1.52Bβ–² +13.0% YoY
Free Cash Flow (TTM)
$571Mβ–² +13.0% YoY

About ELANCO ANIMAL HEALTH INC

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
62/100

Analyst Price Target

β“˜
Average Target
$27.91
β–² +22.8% Upside
High Target$33.98
Low Target$25.36
Based on 15 analysts

Latest News & Updates